Medical Net, Inc. (TSE:3645) agreed to acquire additional 56.4% stake in MiRTeL Co., Ltd from Toshiya Kato, Hidetoshi Tahara, Naoki Tomokami, Eiji Tahara and Yoshino Tahara on November 27, 2023. Prior to the transaction, Medical Net, Inc. held 2.6% stake in MiRTeL. As part of acquisition, 305,501 shares will be acquired. For period ended December 2022, MiRTeL reported net assets of ¥287 million, total assets of ¥516 million, sales of ¥728 million, operating income of ¥177 million and net income of ¥169 million. As of December 21, 2023, Medical Net entered into a contract to acquire additional 12.1% of the shares of MiRTeL from HC No. 8 Fund and High-Value C 1st Fund managed by Hiroshima Venture Capital Co., Ltd., Furusato Renkei Ouen Fund managed by Hiroshima Innovation Network Inc., Will Group Fund Investment Limited Partnership managed by Future Venture Capital Co., Ltd. and 4 others. Following both transactions, Medical Net holds 71.1% stake in MiRTeL. The transaction is expected to complete on January 5, 2024.

Medical Net, Inc. (TSE:3645) completed the acquisition of additional 56.4% stake in MiRTeL Co., Ltd from Toshiya Kato, Hidetoshi Tahara, Naoki Tomokami, Eiji Tahara and Yoshino Tahara on January 5, 2024.